Recent studies indicate that GREM1 is an endogenous inhibitor of Bone Morphogenetic Proteins (BMPs; BMP-2, BMP-4 and BMP-7) and is highly upregulated in fibrotic diseases including in IPF [39–41]. Here, BMP7 is linked to idiopathic pulmonary fibrosis.